Read + Share
Amedeo Smart
Independent Medical Education
Ott SM. In women, bisphosphonate use for >/=3 years vs. <3 months was linked to increased atypical femur fracture risk. Ann Intern Med 2021 Jan 5. doi: 10.7326/ACPJ202101190.PMID: 33395342
Email
LinkedIn
Facebook
Twitter
Privacy Policy